Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
1,628
-2,123
-57% -$1.41M 0.01% 826
2026
Q1
$2.04M Buy
+3,751
New +$1.53M 0.02% 586
2025
Q4
Sell
-1,338
Closed -$361K 1546
2025
Q3
$361K Buy
1,338
+291
+28% +$66.7K ﹤0.01% 1304
2025
Q2
$231K Buy
+1,047
New +$189K ﹤0.01% 1448
2024
Q4
Sell
-8,540
Closed -$866K 1552
2024
Q3
$866K Buy
+8,540
New +$675K 0.01% 843

Other funds holding AGX

Oppenheimer & Co's AGX Position: Q2 2026 in Review

Oppenheimer & Co reduced its Argan (AGX) stake by 57% in Q2 2026, selling an estimated $1.41M and leaving 1,628 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #826.

Oppenheimer & Co first reported a position in AGX in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.04M in Q1 2026. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Oppenheimer & Co held 1,628 shares of Argan worth $1.3M as of Q2 2026.
  • Oppenheimer & Co sold 2,123 Argan shares in Q2 2026, an estimated $1.41M.
  • Argan made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #826 holding.
  • Oppenheimer & Co first reported a position in Argan in Q3 2024 and has held it in 5 quarters since.
  • Oppenheimer & Co's Argan position peaked at $2.04M in Q1 2026.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.